Ann: AstraZeneca to use new ResApp software in clinical study, page-51

When one looks beyond the tip of one's nose and beyond the day's end, this announcement is potentially extremely lucrative.

AZ, has been propelled front and center in the world media because of its efforts to fix the planet. As such its results are more closely scrutinzed than Hunter's laptop. RAP is now, by virtue of its association with AZ also propeeled on to the world stage.

I think it's reasonable to speculate that a few other investors around the planet, looking for an "in" on the vaccination train will wonder, "hmm, what is this RAP thing app?"

Bluntly, RAP is on Big Pharma's watchlists, investors across the globe will watch this angle presenting research results, many will want in. That adds up! Free advertising has started, will snowball, eg. some media outlet somewhere will think, "We need a fresh angle, how 'bout a feel-good story on new tech ("tech," now that's a buzzword!!)," and presto RAP gets more than a nod -- around the world.

That's why I rebought.

OV